Web Analytics

Investor Profile

Pfizer

Pfizer United States - New York, New York
INVESTOR

1 Disclosed Funding Rounds $125,000,000
16 Participating Investments




Breakthroughs That Change Patients' Lives: Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend

Invested In

Company Date Round Raised
  Nimbus Therapeutics September, 13 ,2022 Unknown $125,000,000
  VitaDAO February, 15 ,2023 Unknown $4,100,000
  Mediar Therapeutics March, 15 ,2023 Unknown $105,000,000
  Flare Therapeutics March, 23 ,2023 Series B $123,000,000
  Vedanta Biosciences, Inc. April, 26 ,2023 Unknown $106,500,000
  Mozart Therapeutics, Inc June, 08 ,2023 Series A $25,000,000
  Crossbow Therapeutics, Inc July, 12 ,2023 Series A $80,000,000
  CellCentric July, 24 ,2023 Unknown $25,000,000
  ReCode Therapeutics September, 20 ,2023 Series B $50,000,000
  RefleXion Medical November, 17 ,2023 Unknown $105,000,000
  Curve Therapeutics February, 28 ,2024 Series A $51,183,495
  Mission Therapeutics March, 15 ,2024 Unknown $32,101,650
  Capstan Therapeutics March, 21 ,2024 Series B $175,000,000
  Grey Wolf Therapeutics May, 23 ,2024 Series B $50,000,000
  Enara Bio October, 04 ,2024 Series B $32,500,000
  TRexBio November, 14 ,2024 Series B $84,000,000